NEONC TECHNOLOGIES HOLDINGS, INC. Interest Income, Other
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Interest Income, Other of $334 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. interest income, other for the quarter ending 2026-06-30 was $334.00, a 98.84% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest income, other for the quarter ending 2026-03-31 was $5.20K, a 89.95% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest income, other for the quarter ending 2025-12-31 was $205.00, a 94.05% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest income, other for the quarter ending 2025-09-30 was $6.82K, a 46.28% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest income, other for fiscal 2025 was $327.58K, a 1930.51% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest income, other for fiscal 2024 was $16.13K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $334.00 10-Q · filed 2026-08-10 | $5.53K 10-Q · filed 2026-08-10 | $5.74K derived: sum of 3 quarters · filed 2026-08-10 | $12.55K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $5.20K 10-Q · filed 2026-05-15 | $5.40K derived: sum of 2 quarters · filed 2026-05-15 | $12.22K derived: sum of 3 quarters · filed 2026-05-15 | $40.94K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $205.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.02K derived: sum of 2 quarters · filed 2026-03-31 | $35.74K derived: sum of 3 quarters · filed 2026-08-10 | $327.58K 10-K · filed 2026-03-31 |
| 2025-09-30 | $6.82K 10-Q · filed 2025-11-14 | $35.54K derived: sum of 2 quarters · filed 2026-08-10 | $327.38K 10-Q · filed 2025-11-14 | $90.69K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $28.73K 10-Q · filed 2026-08-10 | $80.42K 10-Q · filed 2026-08-10 | $83.87K derived: sum of 3 quarters · filed 2026-08-10 | $96.56K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $51.70K 10-Q · filed 2026-05-15 | $55.15K derived: sum of 2 quarters · filed 2026-05-15 | $67.83K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $3.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $16.13K derived: sum of 2 quarters · filed 2026-03-31 | $16.13K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $12.69K 10-Q · filed 2025-11-14 | $12.69K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |